Redeye: Idogen - Preparations and capital raise on the agenda
Idogen continues the preparations to get their IDO projects into clinic. To finance the push, a SEK 60 million equity raise has been announced. With this report we provide an update on our take on the case.
Read more and download research update: http://bit.ly/2SEftX8
Start following companies at Redeye to recieve the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/